Related Experiment Video
Updated: Jul 7, 2026

05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Sweet's syndrome in prostate cancer
1Academic Radiotherapy Unit, Royal Marsden Hospital and Institute of Cancer Research, Chelsea, London, UK.
Prostate Cancer and Prostatic Diseases
|January 30, 2008
Summary
Sweet's syndrome, a neutrophilic dermatosis, is linked to cancer. This case highlights a rare occurrence of Sweet's syndrome in a man with prostate cancer undergoing radiotherapy.
Area of Science:
- Dermatology
- Oncology
- Hematology
Background:
- Sweet's syndrome, or acute febrile neutrophilic dermatosis, was first described in 1964.
- It is typically an idiopathic condition predominantly seen in women.
- The syndrome is known to be associated with underlying malignancies, most commonly hematological cancers.
Observation:
- This report details a unique case of Sweet's syndrome in a male patient.
- The patient was undergoing radical radiotherapy for locally advanced prostate cancer.
- This presentation is unusual as Sweet's syndrome is rarely associated with prostate cancer.
Findings:
- The case presents a rare association between prostate cancer and Sweet's syndrome.
- This association is particularly uncommon when other solid or hematological malignancies are absent.
- The patient's treatment for prostate cancer may have influenced the development of Sweet's syndrome.
Implications:
- This case expands the known spectrum of malignancies associated with Sweet's syndrome.
- It suggests a potential link between radiotherapy for prostate cancer and the development of neutrophilic dermatosis.
- Further research is warranted to explore the relationship between prostate cancer, its treatment, and Sweet's syndrome.
More Related Videos
Related Concept Videos
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

